---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-022271"
form_type: "8-K"
ticker: "RFL"
cik: "0001713863"
company_name: "Rafael Holdings, Inc."
filed_at: "2024-03-14T23:59:59+00:00"
generated_at: "2026-06-04T19:52:10.345601+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Rafael Holdings Q2 fiscal 2024 net income $5.9M; Day Three Labs stake raised to 79%

## Summary
- Net income from continuing ops $5.9M ($0.25 diluted EPS) vs loss of $3.3M (-$0.13) YoY.
- Cash and marketable securities $71.7M at Jan 31, 2024.
- Investment in Cyclo Therapeutics contributed $9.7M unrealized gain; Day Three Labs loss $1.6M.
- Increased ownership in Day Three Labs to 79% majority interest; consolidating results.
- Appointed Dr. John Goldberg as Chief Medical Officer.

## SEC filing metadata
- accession: 0001213900-24-022271
- form_type: 8-K
- ticker: RFL
- cik: 0001713863
- company_name: Rafael Holdings, Inc.
- filed_at: 2024-03-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1713863/000121390024022271/0001213900-24-022271-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1713863/000121390024022271/ea0201707-8k_rafael.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-022271
- JSON: https://secwatch.observer/filing/0001213900-24-022271.json
- Plain text: https://secwatch.observer/filing/0001213900-24-022271.txt

## Key facts
- Earnings Releases
  Rafael Holdings, Inc. reported second quarter of fiscal 2024 results: net income net income from continuing operations of $5.9 million, EPS $0.25 per fully diluted share.
  - Period: second quarter of fiscal 2024
  - Net income: net income from continuing operations of $5.9 million
  - EPS: $0.25 per fully diluted share
  - Result: reported results
  source text: For the three months ended January 31, 2024, we recorded net income from continuing operations of $5.9 million, or $0.25 per fully diluted share
  evidence_url: https://www.sec.gov/Archives/edgar/data/1713863/000121390024022271/0001213900-24-022271-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.